⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23045105 | 1.00 | — | — | |
| SCHEMBL4958294 | 1.00 | — | — | |
| SCHEMBL27886041 | 0.85 | — | — | |
| SCHEMBL23013161 | 0.83 | SQLE (0.44) | — | |
| SCHEMBL2162927 | 0.79 | — | — | |
| SCHEMBL2162929 | 0.79 | — | — | |
| SCHEMBL28242436 | 0.77 | — | — | |
| SCHEMBL11436605 | 0.75 | BTN3A1 (0.44) | — | |
| SCHEMBL11436601 | 0.75 | BTN3A1 (0.44) | — | |
| SCHEMBL954112 | 0.73 | KMT2A (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10576126-B2 | Antitumor agent | NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL UNIVERSITY (JP) | 2020-03-03 | — | — | US | disclosed |
| US-20190022172-A1 | ANTITUMOR AGENT | NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL MEDICAL (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3400952-A1 | ANTITUMOR AGENT | National University Corporation Asahikawa Medical University (JP) | 2018-11-14 | — | — | EP | disclosed |
| WO-2017126626-A1 | ANTITUMOR AGENT | 国立大学法人旭川医科大学 | 2017-07-27 | — | — | WO | disclosed |
| US-20080113899-A1 | Iron Supplement and Utilization of the Same | GEKKEIKAN SAKE CO., LTD. (JP) | 2008-05-15 | — | — | US | disclosed |
| EP-1704871-A1 | IRON SUPPLEMENT AND UTILIZATION OF THE SAME | Gekkeikan Sake Co., Ltd. (JP) | 2006-09-27 | — | — | EP | disclosed |